ArticleAntibody therapeutics2024
Correction to: Role of antibody engineering in generation of derivatives starting from MOv19 MAb: 40 years of biological/therapeutic tools against folate receptor alfa.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.